** Abbott India NSE:ABBOTINDIA jumps 3.5% post Q4 results
** Drugmaker's profit rises 28% y/y in Q4; rev from ops up 11%
** Co's earnings boosted by strong demand for gastrointestinal and anti-infective drugs
** Stock is top gainer in nifty pharma index NSE:CNXPHARMA, which is down 0.4%
** YTD shares up 2%, set to extend gains for a second straight session
** Broader market nifty 50 index NSE:NIFTY down 0.2% on Friday